Global Life Science CDMO Supply, Demand and Key Producers, 2024-2030

Global Life Science CDMO Supply, Demand and Key Producers, 2024-2030

The global Life Science CDMO market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Life Science CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Life Science CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Life Science CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Life Science CDMO total market, 2019-2030, (USD Million)

Global Life Science CDMO total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Life Science CDMO total market, key domestic companies and share, (USD Million)

Global Life Science CDMO revenue by player and market share 2019-2024, (USD Million)

Global Life Science CDMO total market by Type, CAGR, 2019-2030, (USD Million)

Global Life Science CDMO total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Life Science CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Catalent, WuXi Biologics, Samsung Biologics, Siegfried, Fujifilm Diosynth Biotechnologies, Lars Petersen and Recipharm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Life Science CDMO market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Life Science CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Life Science CDMO Market, Segmentation by Type
Active Pharmaceutical Ingredient (API) CDMO
Biologics CDMO
Finished Dosage Form (FDF) CDMO
Others

Global Life Science CDMO Market, Segmentation by Application
Pharmaceutical
Clinical
Research

Companies Profiled:
Lonza Group
Thermo Fisher Scientific
Catalent
WuXi Biologics
Samsung Biologics
Siegfried
Fujifilm Diosynth Biotechnologies
Lars Petersen
Recipharm
Boehringer Ingelheim
MilliporeSigma
Aenova Group
AGC Parma Chemicals
GenScript
Novartis
Sai Life Sciences

Key Questions Answered

1. How big is the global Life Science CDMO market?

2. What is the demand of the global Life Science CDMO market?

3. What is the year over year growth of the global Life Science CDMO market?

4. What is the total value of the global Life Science CDMO market?

5. Who are the major players in the global Life Science CDMO market?